An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)
Clinical trial NCT03202368 · COMPLETED
Trial details
- NCT number
- NCT03202368
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-25
- Primary completion
- 2019-08-21
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.